Celecoxib/hydrochlorothiazide(Adhera Therapeutics)

N/A

Report date: 2025/12/18 17:47:04

Base Information

Drug NameCelecoxib/hydrochlorothiazide(Adhera Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsCyclooxygenase-2Thiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes CelecoxibHydrochlorothiazide
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMarina Biotech
China Registration ClassN/A

Develop Information

Active CompaniesMarina Biotech
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A